Interleukin-6--a key regulator of colorectal cancer development.
about
Cytokine-Induced Modulation of Colorectal CancerDiagnostic and Prognostic Value of Serum Interleukin-6 in Colorectal CancerRole of TH17 cytokines in the control of colorectal cancerBamboo vinegar decreases inflammatory mediator expression and NLRP3 inflammasome activation by inhibiting reactive oxygen species generation and protein kinase C-α/δ activationIL-6 secreted by cancer-associated fibroblasts promotes epithelial-mesenchymal transition and metastasis of gastric cancer via JAK2/STAT3 signaling pathwayAcute inflammation induced by the biopsy of mouse mammary tumors promotes the development of metastasis.Expression of pattern recognition receptor genes and mortality in patients with colorectal adenocarcinoma.Role of microRNAs in resveratrol-mediated mitigation of colitis-associated tumorigenesis in Apc(Min/+) mice.Involvement of NF-κB/IL-6 Pathway in the Processing of Colorectal Carcinogenesis in Colitis MiceMucin 2 silencing promotes colon cancer metastasis through interleukin-6 signaling.A coding IRAK2 protein variant compromises Toll-like receptor (TLR) signaling and is associated with colorectal cancer survival.Cross talk between the TM4SF5/focal adhesion kinase and the interleukin-6/STAT3 pathways promotes immune escape of human liver cancer cells.IL-6/STAT3 promotes regeneration of airway ciliated cells from basal stem cells.A phase II trial of dasatinib in patients with metastatic castration-resistant prostate cancer treated previously with chemotherapy.Neutrophil:lymphocyte ratios and serum cytokine changes after hepatic artery chimeric antigen receptor-modified T-cell infusions for liver metastasesDismicrobism in inflammatory bowel disease and colorectal cancer: changes in response of colocytes.Identification of Novel Biomarkers for Metastatic Colorectal Cancer Using Angiogenesis-Antibody Array and Intracellular Signaling Array.Tumor-targeting peptides from combinatorial libraries.Glucosamine Downregulates the IL-1β-Induced Expression of Proinflammatory Cytokine Genes in Human Synovial MH7A Cells by O-GlcNAc Modification-Dependent and -Independent Mechanisms.Diminished expression of CRHR2 in human colon cancer promotes tumor growth and EMT via persistent IL-6/Stat3 signalingA novel model of colitis-associated cancer in SAMP1/YitFc mice with Crohn's disease-like ileitis.Prognostic and clinicopathological significance of serum interleukin-6 expression in colorectal cancer: a systematic review and meta-analysis.Cryoablation and Meriva have strong therapeutic effect on triple-negative breast cancer.ILs-3, 6 and 11 increase, but ILs-10 and 24 decrease stemness of human prostate cancer cells in vitro.Inhibition of p300 lysine acetyltransferase activity by luteolin reduces tumor growth in head and neck squamous cell carcinoma (HNSCC) xenograft mouse model.Radiation and SN38 treatments modulate the expression of microRNAs, cytokines and chemokines in colon cancer cells in a p53-directed mannerThe Innate Immune Receptor NLRX1 Functions as a Tumor Suppressor by Reducing Colon Tumorigenesis and Key Tumor-Promoting Signals.Prognostic Impact of IL6 Genetic Variants in Patients with Metastatic Colorectal Cancer Treated with Bevacizumab-Based Chemotherapy.High-fat diets rich in saturated fat protect against azoxymethane/dextran sulfate sodium-induced colon cancer.Cancer-related inflammation as predicting tool for treatment outcome in locally advanced and metastatic non-small cell lung cancer.Sepiapterin ameliorates chemically induced murine colitis and azoxymethane-induced colon cancer.miR-181b functions as an oncomiR in colorectal cancer by targeting PDCD4Nicotinamide phosphoribosyltransferase in malignancy: a review.Increased preventive effect on colon carcinogenesis by use of resistant starch (RS3) as the carrier for polysaccharide of Larimichthys crocea swimming bladder.Interleukin-6 promotes tumor progression in colitis-associated colorectal cancer through HIF-1α regulation.Ovatodiolide suppresses colon tumorigenesis and prevents polarization of M2 tumor-associated macrophages through YAP oncogenic pathways.Interleukin-6 and C-reactive protein as prognostic biomarkers in metastatic colorectal cancer.Clinicopathological significance of overexpression of interleukin-6 in colorectal cancer.The Pretreatment Systemic Inflammatory Response is an Important Determinant of Poor Pathologic Response for Patients Undergoing Neoadjuvant Therapy for Rectal CancerTargeting interleukins for the treatment of inflammatory bowel disease-what lies beyond anti-TNF therapy?
P2860
Q26752374-C2FA6C39-3112-4D1E-9DF6-3CAB4A579DE1Q26772049-1AFD5B94-5BC0-4E29-9927-69EC68A07689Q26860784-7A574175-C937-4083-BA51-6821DE46E1DCQ28534131-3AC7EF46-A26A-41AC-9BD0-4EF1D0569793Q33591332-58963AC8-558A-42F8-8408-A67F55B61FA6Q33683707-BB8B4155-F01D-4976-BF69-5F80B70BA7A0Q33700384-D302EE36-5EC6-408E-BF26-0CD54711589FQ33750847-B5077BBF-788B-4225-97F0-2B270388BEEFQ33908674-116ECAD0-59C5-4173-B7E1-4DBACF3F5FA2Q33918398-2C517B3A-D33E-4A23-95EC-5E692DBDA1D6Q34044755-22C7F46C-B0ED-4225-B95A-B495F870AD6DQ34056571-ED862C33-B4F3-4AF7-B590-9B3814035D5BQ34144162-3CA08262-F146-4C57-818A-7F054BDCCE60Q34194110-08D9BD04-345D-4A97-8D37-0D714B536175Q34577127-9AB9307D-7437-4917-B145-CF8A399F0A1DQ34779075-FC5B9341-F9BD-40A7-886D-E66E29BD350EQ35741252-60E0FCA9-BA06-4CAC-8D15-17297B35660CQ36025723-472CDD60-14AD-4A7A-9B05-49F05526207FQ36173158-376526D1-886B-45AF-8EA3-8C9924A9C9EAQ36174823-07ADDF46-5D59-4D32-9135-9301A1A98A21Q36310800-6817EB61-FA59-4134-B44A-B24AB9C4FFDFQ36399064-C704E04C-C94C-4E58-AFF8-BA74EAA0C315Q36597502-CA151488-B3EB-40FB-97C2-02D65D67C75BQ36618978-669214C4-A840-4E49-B523-5CDE54F3A67EQ36685513-ACA18682-4BF5-45C0-9FC6-B2C6C0842ED5Q36689088-2872317E-A89E-4D18-9107-A5FE3FEA7DA7Q36860902-5DC18C63-0635-4FCF-BF35-185DA75A1D4AQ37059793-E5E2F375-8D9F-404D-882A-7E962F258161Q37071779-72DE138A-CF26-458E-8541-D086956111D7Q37121339-F0C6AA98-DAC7-4A9A-864E-800AA7EADE5BQ37193196-DDF0E498-5922-42F1-8BBE-48DF6FA4BCEEQ37321736-A92A2F7E-C163-447B-8EBC-70636E4A12E1Q37424391-E5C9A97E-1C77-4C0C-A0DB-7EC6EDBEEE83Q37535542-3AE3D817-2071-4045-B103-D26A37C5726AQ37582274-91B27FE5-B8D4-4C95-9AE5-A7595631BF1BQ37671165-CA6E713E-2373-4E45-A99C-1C2001B913D3Q37688887-BA35B994-745B-4DB5-8DE3-E684419E04CDQ37703500-6E19133B-14DD-409F-A90C-EE29D390E1E4Q37730979-42FCF19D-066C-4016-88E6-E5215C3803FEQ38172801-7F822039-D7E1-4245-B25A-5926C76B97FA
P2860
Interleukin-6--a key regulator of colorectal cancer development.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Interleukin-6--a key regulator of colorectal cancer development.
@en
type
label
Interleukin-6--a key regulator of colorectal cancer development.
@en
prefLabel
Interleukin-6--a key regulator of colorectal cancer development.
@en
P2860
P921
P356
P1476
Interleukin-6--a key regulator of colorectal cancer development
@en
P2093
Markus F Neurath
Sebastian Foersch
P2860
P304
P356
10.7150/IJBS.4614
P407
P5008
P577
2012-10-24T00:00:00Z